Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Norris Medicines Ltd (NSE: NORRIS), ISIN INE744C01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NORRIS last traded at ₹15.00 (+0.00%), with a 52-week range of ₹12.00 to ₹20.06 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 34.01%, FIIs 0.00%, DIIs 0.07%, mutual funds 0.01%.
EquiSense Score (ECS): 10/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.